Hidradenitis suppurativa disease course during pregnancy and postpartum: a retrospective survey study

L M Prens¹, M L Porter^{2

3}, K T Savage², P Salian², B Horváth¹, A B Kimball^{2

3}

Affiliations

¹ Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
² Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA.
³ Harvard Medical School, Boston, MA, 02215, USA.

L M Prens et al. Br J Dermatol. 2021 Nov.

. 2021 Nov;185(5):1072-1074.

doi: 10.1111/bjd.20078. Epub 2021 Sep 14.

L M Prens¹, M L Porter^{2

3}, K T Savage², P Salian², B Horváth¹, A B Kimball^{2

3}

¹ Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
² Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA.
³ Harvard Medical School, Boston, MA, 02215, USA.

No abstract available

References

1. Martorell A, García-Martínez F, Jiménez-Gallo D et␣al. An update on hidradenitis suppurativa (Part I): epidemiology, clinical aspects, and definition of disease severity. Actas Dermosifiliogr 2015; 106:703-15.
1. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009; 60:539-61.
1. Karagiannidis I, Nikolakis G, Zouboulis CC. Endocrinologic aspects of hidradenitis suppurativa. Dermatol Clin 2016; 34:45-9.
1. Jemec GBE. Hidradenitis suppurativa. N Engl J Med 2012; 366:158-64.
1. Nazary M, van der Zee HH, Prens EP et␣al. Pathogenesis and pharmacotherapy of hidradenitis suppurativa. Eur J Pharmacol 2011; 672:1-8.